Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 1814-1819, September 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Webb, D.
Right arrow Articles by Plescia, O. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Webb, D.
Right arrow Articles by Plescia, O. J.

Antitumor Effects of Polynucleotides and Theophylline1

David Webb2, Werner Braun and Otto J. Plescia

Institute of Microbiology, Rutgers University, New Brunswick, New Jersey 08903

Polyadenylic-polyuridylic acid and polyinosinic-polycytidylic acid, as well as theophylline, retard the rate of intradermal growth of Rauscher leukemia virus-induced ascites tumor cells in syngeneic BALB/c mice. The combination of polyadenylic-polyuridylic acid and theophylline tends to affect the growth more than either agent alone, the results being dependent on dosages, timing, and the tumor cell line used. A substantial part of the antitumor activity of these agents, which are also known to modify immune responses, appears to be due to a direct effect on the tumor cells, since the effects of polyadenylic-polyuridylic acid and theophylline were also observed in irradiated mice and usually also after direct treatment of the tumor cells in vitro prior to implantation. In view of data from other cell systems, which show that synthetic polynucleotides stimulate the enzyme responsible for the formation of cyclic adenosine 3',5'-monophosphate and also in view of the fact that theophylline inhibits the enzymes that degrade cyclic adenosine 3',5'-monophosphate, the inhibitory effects noted here are believed to involve alterations in the cyclic adenosine 3',5'-monophosphate system of the tumor cells.

1 This work was supported by NIH Grants AI 08493 and AI 09343, National Science Foundation Grant GB 20162, and a grant frmm the New York Cancer Research Institute.

2 Present address: Section of Hematology and Immunology, Dept. of Medicine, University of California School of Medicine, San Francisco, Calif. 94122.

Received 11/ 5/71. Accepted 5/11/72.




This article has been cited by other articles:


Home page
Journal of Bioactive and Compatible PolymersHome page
L. Seymour
Review : Synthetic Polymers with Intrinsic Anticancer Activity
Journal of Bioactive and Compatible Polymers, January 1, 1991; 6(2): 178 - 216.
[PDF]


Home page
ScienceHome page
Y. S. Cho-Chung and P. M. Gullino
In vivo Inhibition of Growth of Two Hormone-Dependent Mammary Tumors by Dibutyryl Cyclic AMP
Science, January 11, 1974; 183(4120): 87 - 88.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.